Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shenzhen - Delayed Quote CNY

Xi'an International Medical Investment Company Limited (000516.SZ)

Compare
5.01
-0.03
(-0.60%)
As of 1:18:57 PM GMT+8. Market Open.
Loading Chart for 000516.SZ
  • Previous Close 5.04
  • Open 5.48
  • Bid 5.00 x --
  • Ask 5.01 x --
  • Day's Range 4.95 - 5.15
  • 52 Week Range 4.01 - 6.77
  • Volume 24,966,174
  • Avg. Volume 45,766,415
  • Market Cap (intraday) 11.325B
  • Beta (5Y Monthly) 1.08
  • PE Ratio (TTM) --
  • EPS (TTM) -0.16
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 28, 2019
  • 1y Target Est 7.20

Xi'an International Medical Investment Company Limited provides healthcare services. It operates hospitals and medical centers. It also engages in insurance broking, tourism, and pharmaceutical production business. The company was formerly known as Xi'an Kaiyuan Investment Group Co., Ltd. and changed its name to Xi'an International Medical Investment Company Limited in January 2015. The company was founded in 1986 and is based in Xi'an, China.

www.000516.cn

8,173

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 000516.SZ

View More

Performance Overview: 000516.SZ

Trailing total returns as of 4/8/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000516.SZ
5.11%
SSE Composite Index (000001.SS)
7.22%

1-Year Return

000516.SZ
15.66%
SSE Composite Index (000001.SS)
2.06%

3-Year Return

000516.SZ
40.29%
SSE Composite Index (000001.SS)
4.37%

5-Year Return

000516.SZ
18.16%
SSE Composite Index (000001.SS)
10.46%

Compare To: 000516.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 000516.SZ

View More

Valuation Measures

Annual
As of 4/7/2025
  • Market Cap

    11.39B

  • Enterprise Value

    15.40B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.35

  • Price/Book (mrq)

    3.12

  • Enterprise Value/Revenue

    3.15

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.34%

  • Return on Assets (ttm)

    -1.34%

  • Return on Equity (ttm)

    -12.92%

  • Revenue (ttm)

    4.88B

  • Net Income Avi to Common (ttm)

    -358.15M

  • Diluted EPS (ttm)

    -0.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    499.97M

  • Total Debt/Equity (mrq)

    129.52%

  • Levered Free Cash Flow (ttm)

    46.45M

Research Analysis: 000516.SZ

View More

Company Insights: 000516.SZ

Research Reports: 000516.SZ

View More

People Also Watch